Cleo Diagnostics Ltd (ASX:COV)
Australia · Delayed Price · Currency is AUD 0.3250
-0.0250 (-7.14%)
Oct 7, 2026, 3:55 PM AEST
Cleo Diagnostics Market Cap
Cleo Diagnostics has a market cap or net worth of 43.88 million as of October 7, 2026. That makes Cleo Diagnostics the world's 34,103rd most valuable company and 846th in Australia. Its market cap has decreased by 3.82% in one year.
Market Cap
43.88M
Enterprise Value
37.65M
Revenue
1.72M
Global Rank
Country Rank
#846 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since August 15, 2023, Cleo Diagnostics's market cap has increased from 25.70M to 43.88M, an increase of 70.72%. That is a compound annual growth rate of 18.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 43.88M | -47.01% |
| Dec 31, 2025 | 82.80M | 81.51% |
| Dec 31, 2024 | 45.62M | 102.86% |
| Dec 29, 2023 | 22.49M | -12.50% |
| Aug 15, 2023 | 25.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lumos Diagnostics Holdings | 103.93M |
| SomnoMed | 63.73M |
| Epiminder | 58.50M |
| Cyclopharm | 57.84M |
| Compumedics | 51.94M |
| HeraMED | 49.82M |
| Micro-X | 40.63M |
| CleanSpace Holdings | 38.89M |